ZACTIFY Trademark

Trademark Overview


On Friday, June 4, 2021, a trademark application was filed for ZACTIFY with the United States Patent and Trademark Office. The USPTO has given the ZACTIFY trademark a serial number of 79320409. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by NOVARTIS AG. The ZACTIFY trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
zactify

General Information


Serial Number79320409
Word MarkZACTIFY
Filing DateFriday, June 4, 2021
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7393751
Registration DateTuesday, May 28, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, October 19, 2021ASSIGNED TO EXAMINER
Thursday, September 16, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, September 20, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, September 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 1, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, October 26, 2021NON-FINAL ACTION WRITTEN
Wednesday, December 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 27, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 26, 2021REFUSAL PROCESSED BY MPU
Friday, November 26, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, December 19, 2021REFUSAL PROCESSED BY IB
Wednesday, December 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 1, 2022SUSPENSION LETTER WRITTEN
Friday, April 1, 2022LETTER OF SUSPENSION E-MAILED
Friday, April 1, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, February 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 18, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, March 14, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, February 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 21, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 11, 2024NOTIFICATION PROCESSED BY IB
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, January 10, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, May 31, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED